Biotech buyout? Teva's $40 billion bid

mardi 21 avril 2015

Biotech buyout? Teva's $40 billion bidTeva is offering $40 billion to buy Mylan. Barbara Ryan, Clemont Partners, and CNBC's Meg Tirrell, provide perspective on the potential consolidation.




via Business News http://ift.tt/1G4qWR8

0 commentaires:

Enregistrer un commentaire